公司資料
Veeva 股價、新聞與催化劑
- 股票代碼:
- VEEV
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
281.93 USD (-1.23%)
收盤價
最後更新: 2026年10月1日
29.9B USD
市值
股價為何變動
截至 2026年10月1日，VEEV 下跌 1.23%，收於 $281.93。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Life Sciences Industry Cloud Company
Veeva Systems provides cloud applications, data products, artificial intelligence agents, and consulting services purpose-built for life sciences. Its customers range from emerging biotechnology companies to the world's largest pharmaceutical manufacturers.
Commercial Cloud
Veeva Commercial Cloud includes Vault CRM, content, data, analytics, and customer-engagement applications used by sales, marketing, and medical teams. The suite supports regulated interactions with healthcare professionals and coordinated product commercialization.
Development and Quality Cloud
Development Cloud and Quality Cloud support clinical operations, regulatory information, safety, quality management, training, and manufacturing documentation. These applications create a connected foundation for managing regulated content and processes across the product lifecycle.
Data and Consulting Services
Veeva combines software with reference data, patient and prescriber data products, and consulting. This integrated model helps customers implement common data standards and execute commercial and development programs on the same industry-specific platform.
AI Agents and Falcon Platform
Veeva is embedding standard and configurable agents into Vault applications while developing Falcon as an agentic labor platform for clinical, regulatory, and safety work. The strategy applies AI within governed life-sciences workflows rather than offering a general-purpose horizontal tool.
未來催化劑
- Initial customer go-lives for the Veeva Falcon agentic labor platform by year-end 2026.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。